ASTC Astrotech Corporation - Common Stock
Astrotech Corporation - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
Devamını oku
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
Astrotech Corporation was established in 1984. Prior to 2009, it was known as SPACEHAB, Inc., a company that provided space habitat microgravity experimentation equipment and services to NASA during the Space Shuttle era. As the Shuttle program came to an end, the company put more focus on its spacecraft processing business, Astrotech Space Operations, Inc. (ASO), its mass spectrometer instrumentation business, 1st Detect, Inc. and its microgravity vaccine development company, Astrogenetix, Inc. In August 2014, the company sold Astrotech Space Operations. In February 2015, the company acquired defect correction software and Astral Images Corp. was created to commercialize government funded satellite imagery processing technology and research into automated image correction and enhancement.
Spacehab (1984–2009)
Spacehab was founded in 1984 by Bob Citron with the help and support of CSP Associates from Cambridge, Massachusetts. The team from CSP Associates included founder David W. Lippy along with his partners Brad Meslin and Marc Oderman. It was one of CSP's consultants, Dr. David Williamson who conceived of the idea to increase the cargo space on the Shuttles as the primary focus of the Spacehab mission. Early venture capital was supplied by Al Zesiger of BEA Associates in New York City as well as Dr. Shelley Harrison also from New York. CSP Associates and its venture contacts were responsible for raising most of the early seed money to get the company off the ground and funded. Throughout its more than 20-year history, Spacehab has contracted over $1 billion dollars in total sales.
Spacehab hardware for Space Shuttle missions
Spacehab hardware consisted of:
Integrated Cargo Carrier (ICC), unpressurized
External Stowage Platform (ESP-2 and ESP-3), an ICC variant
Logistics Single Module (LSM) and Logistics Double Module (LDM)
Single Module (SM) and Research Double Module (RDM), pressurized
The Spacehab hardware was designed to be nestled inside the cargo bay of the Space Shuttles and flew on 22 Space Shuttle missions, including seven to the Russian space station Mir and eight to the International Space Station (ISS). The Single Module flew on seven missions, and the Research Double Module flew only on the ill-fated Columbia STS-107 mission, in which it was destroyed.
The inaugural flight of Spacehab's research double module, which launched January 2003 on STS-107, ended when the Space Shuttle Columbia broke up during re-entry. In February 2003 Spacehab received $17.7 million from its commercial insurance policy. In January 2004, Spacehab filed a formal claim against NASA for the amount of $87.7 million for the loss caused by the Columbia disaster and in October 2004 NASA paid the company $8.2 million. In February 2007, Spacehab dropped all litigation against NASA.
Spacehab's ICC hardware was further developed into the External Stowage Platform (ESP-2 and ESP-1), which are permanently deployed on the ISS. The ESP-2 is attached to the International Space Station's airlock, providing the only permanent, commercial "spare parts" facility for the ISS crew. ESP-3 was deployed during Space Shuttle mission STS-118, on August 8, 2007.
Flights
Legend:
ESP - External Stowage Platform
ICC - Integrated Cargo Carrier
LDM - Logistics Double Module
LSM - Logistics Single Module
SM - Single Module
RDM - Research Double Module
Astrotech Corporation (2009–present)
The Company changed its name to Astrotech Corporation in 2009 to align the corporate name with the company's core business offering, Astrotech Space Operation. ASO provides all support necessary for government and commercial customers to successfully process their satellite hardware for launch–including planning; construction and use of unique equipment and facilities; and spacecraft checkout, encapsulation, fueling, and transport. Astrotech Corporation management sold ASO, its state-of-the-art satellite servicing operations, to Lockheed Martin in August 2014.
Chemical detection and analysis
1st Detect, an Astrotech subsidiary, develops, manufactures, and sells mass spectrometers that can be used in explosive and chemical warfare detection for the Department of Homeland Security and the military. 1st Detect's miniature mass spectrometer technology was sourced from Oak Ridge National Laboratory's chemical analyzer research.
The company Astrotech Corporation (NASDAQ: ASTC) announced that its Astrotech Technologies, Inc. subsidiary had entered into an agreement with Sanmina Corporation to manufacture its mass spectrometry products. As part of the relationship, Sanmina will manufacture 1st Detect's TRACER 1000. They also agreed to manufacture AgLAB's AgLAB-1000 and BreathTech's BreathTest-1000 once those products are released.
Film restoration, correction, and enhancement
Astral Images sells conversion of film to digital images, using defect removal and color correction software, and post processing services, providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Astral Images' core technology is sourced from decades of image research from the laboratories of IBM and Kodak combined with classified satellite technology from government laboratories.
Vaccine development
Sourced from NASA's extensive microgravity research, Astrogenetix is applying a fast-track on-orbit discovery platform using the International Space Station to develop vaccines and other therapeutics.
Space operations
Prior to the 2014 Lockheed Martin acquisition, Astrotech provided both the government and commercial space markets with satellite processing services through its Astrotech Space Operations (ASO) subsidiary located in Titusville, Florida, three miles (5 km) from the Kennedy Space Center. It has more than 150,000 square feet (14,000 m2) of clean room processing space, and services payloads, or satellites, for United Launch Alliance's Atlas and Delta rocket families, Orbital Sciences' Taurus and Pegasus, and SpaceX's Falcon 9 launch vehicles. Astrotech owned and operated processing facilities located on Vandenberg Space Force Base at the Western Range in California. Also in California, ASO provided payload processing and facilities management support for the ocean-going Sea Launch program at the Home Port Facilities in Long Beach.
ARCTUS
On December 10, 2007, Spacehab released details about its planned Advanced Research and Conventional Technology Utilization Spacecraft designed to deliver cargo to, and return cargo from, the International Space Station. The project was later shelved.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
ASTC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
ASTC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
ASTC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 2 28,6%
- Al 4 57,1%
- Tut 1 14,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2024 | $-1.79 | — | — |
| 31 Aralık 2016 | $-19.50 | $-18.36 | -1.1% |
| 30 Eylül 2016 | $-25.50 | $-24.48 | -1.0% |
| 30 Haziran 2000 | $0.00 | $15.30 | -15.3% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ASTC | $10M | -48.2 | -41.2% | -1385.0% | -55.2% | 47.5% |
| REFR | — | -21.8 | -16.0% | — | — | — |
| MSAI | — | — | — | — | — | — |
| KEYS | $36.97B | 37.3 | 8.0% | 15.8% | 15.5% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $750.0K | $869.0K | $334.0K | $488.0K | $127.0K | $86.0K | $2M | $3M | $513.0K | $130.0K | |
| Cost of Revenue | $574.0K | $913.0K | $444.0K | $677.0K | $298.0K | $449.0K | $90.0K | $36.0K | $1M | $2M | $424.0K | $0 | |
| Gross Profit | $475.0K | $751.0K | $306.0K | $192.0K | $36.0K | $39.0K | $37.0K | $50.0K | $1M | $339.0K | $89.0K | $130.0K | |
| R&D Expense | $8M | $7M | $6M | $3M | $3M | $3M | $4M | $6M | $6M | $6M | $3M | $3M | |
| SG&A Expense | $7M | $7M | $6M | $6M | $5M | $5M | $5M | $6M | $8M | $8M | $13M | $8M | |
| Operating Expenses | $15M | $14M | $11M | $9M | $8M | $8M | $8M | $13M | $13M | $14M | $16M | $11M | |
| Operating Income | $-15M | $-13M | $-11M | $-9M | $-8M | $-8M | $-8M | $-13M | $-12M | $-14M | $-16M | $-10M | |
| Other Non-op | $886.0K | $2M | $1M | $265.0K | $-235.0K | $-197.0K | $25.0K | $86.0K | $306.0K | $379.0K | $224.0K | $11.0K | |
| Pretax Income | $-14M | $-12M | $-10M | $-8M | $-8M | $-8M | $-8M | $-13M | $-12M | $-13M | $-16M | $-10M | |
| Income Tax | $2.0K | $2.0K | $0 | $0 | $0 | $0 | $-858.0K | $0 | $2.0K | $-25.0K | $-6M | $-4M | |
| Net Income | $-14M | $-12M | $-10M | $-8M | $-8M | $-8M | $-8M | $-13M | $-12M | $-13M | $11M | $-5M | |
| EPS (Basic) | $-8.32 | $-7.12 | $-5.95 | $-5.24 | $-0.35 | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,665,000 | 1,638,000 | 1,620,000 | 1,590,000 | 21,984,000 | · | · | · | · | · | · | · | |
| EBITDA | $-15M | $-13M | $-11M | $-8M | $-8M | $-8M | $-8M | · | $-11M | $-13M | $-16M | · |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $21M | $28M | $26M | $36M | $3M | $2M | $552.0K | $2M | $4M | $2M | $4M | |
| Short-term Investments | $15M | $21M | $28M | $26M | $27M | $0 | · | $4M | $11M | $17M | $23M | $0 | |
| Receivables | $485.0K | $77.0K | $225.0K | $56.0K | $5.0K | $101.0K | $3.0K | $12.0K | $146.0K | $156.0K | $198.0K | $59.0K | |
| Inventory | · | · | · | · | · | · | · | $7.0K | $166.0K | $496.0K | $509.0K | $0 | |
| Prepaid Expense | $353.0K | $261.0K | $365.0K | $748.0K | $318.0K | $117.0K | $371.0K | $154.0K | $269.0K | $319.0K | $296.0K | $389.0K | |
| Current Assets | $22M | $35M | $45M | $55M | $65M | $5M | $3M | $4M | $14M | $23M | $33M | $6M | |
| PP&E (Net) | $2M | $3M | $3M | $1M | $263.0K | $99.0K | $469.0K | $733.0K | $3M | $3M | $3M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $2M | $1M | $3M | $3M | $3M | $5M | $5M | $6M | $4M | |
| Accum. Depreciation | $2M | $2M | $1M | $779.0K | $774.0K | $3M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Intangibles | $48.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $346.0K | $30.0K | $30.0K | $11.0K | $11.0K | $71.0K | $72.0K | $81.0K | $0 | · | · | · | |
| Total Assets | $27M | $38M | $48M | $56M | $66M | $6M | $4M | $5M | $19M | $31M | $44M | $41M | |
| Accounts Payable | $1M | $373.0K | $546.0K | $169.0K | $396.0K | $239.0K | $160.0K | $112.0K | $259.0K | $237.0K | $398.0K | $996.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $641.0K | $2M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | $210.0K | · | · | · | · | · | · | |
| Current Liabilities | $2M | $3M | $3M | $3M | $4M | $4M | $838.0K | $960.0K | $2M | $2M | $2M | $10M | |
| Capital Leases | $2M | $0 | $130.0K | · | $185.0K | $583.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $146.0K | $188.0K | $256.0K | $96.0K | $101.0K | $152.0K | |
| Total Liabilities | $5M | $3M | $3M | $3M | $4M | $5M | $984.0K | $1M | $2M | $2M | $2M | $10M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | · | |
| Total Debt | · | · | · | · | · | $210.0K | · | · | · | · | · | · | |
| Common Stock | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $190M | $189M | $189M | $184M | |
| Paid-in Capital | $83M | $82M | $81M | $80M | $78M | $14M | $8M | $2M | $1M | $1M | $1M | $2M | |
| Retained Earnings | $-251M | $-237M | $-225M | $-216M | $-207M | $-200M | $-192M | $-184M | $-171M | $-159M | $-146M | $-157M | |
| Treasury Stock | $119.0K | $119.0K | $119.0K | $0 | · | $4M | $4M | $4M | $4M | $3M | $3M | $237.0K | |
| AOCI | $-864.0K | $-1M | $-1M | $-1M | $-23.0K | · | · | $-31.0K | $-61.0K | $-101.0K | $-23.0K | $0 | |
| Stockholders' Equity | $22M | $35M | $45M | $53M | $61M | $625.0K | $3M | $4M | $17M | $29M | $41M | $28M | |
| Liabilities + Equity | $27M | $38M | $48M | $56M | $66M | $6M | $4M | $5M | $19M | $31M | $44M | $41M | |
| Shares Outstanding | 1,758,953 | 1,701,729 | 1,681,729 | 1,685,595 | 49,450,558 | 7,850,362 | 5,775,171 | 4,097,346 | 4,111,281 | 20,627,511 | 20,743,973 | 19,544,794 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $962.0K | $731.0K | $366.0K | $236.0K | $203.0K | $533.0K | $268.0K | $749.0K | $711.0K | $600.0K | $300.0K | $306.0K | |
| Stock-based Comp | $830.0K | $1M | $1M | $2M | $626.0K | $348.0K | $305.0K | $450.0K | $1M | $551.0K | $5M | $646.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-429.0K | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | $-233.0K | $-636.0K | $499.0K | $-1M | · | $927.0K | $-1M | · | · | |
| Operating Cash Flow | $-13M | $-10M | $-8M | $-7M | $-7M | $-7M | $-8M | $-11M | $-9M | $-13M | $-11M | $-552.0K | |
| CapEx | $833.0K | $579.0K | $2M | $596.0K | $211.0K | $0 | $0 | $19.0K | $499.0K | $809.0K | $2M | $150.0K | |
| Investing Cash Flow | $6M | $6M | $-4M | $-596.0K | $-28M | $0 | $4M | $9M | $8M | $16M | $19M | $-368.0K | |
| Stock Issued | · | · | · | $0 | $68M | $6M | $6M | $0 | $18.0K | $16.0K | $112.0K | $42.0K | |
| Stock Repurchased | · | $0 | $119.0K | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | $-119.0K | $0 | $68M | $6M | $6M | · | $18.0K | $16.0K | $112.0K | · | |
| Financing Cash Flow | $-185.0K | $-181.0K | $-776.0K | $-2M | $68M | $9M | $6M | $-7.0K | $-1M | $-140.0K | $-10M | $-345.0K | |
| Net Change in Cash | $-7M | $-4M | $-12M | $-9M | $33M | $2M | $1M | $-2M | $-2M | $2M | $-2M | $-1M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $0 | $198.0K | $0 | · | |
| Free Cash Flow | $-14M | $-10M | $-9M | $-7M | $-8M | · | $-8M | · | $-9M | $-14M | $-13M | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.5% | 44.2% | 40.8% | 22.1% | 10.8% | 8.0% | 29.1% | · | 44.5% | 12.7% | 17.3% | · | |
| Operating Margin | -1473.4% | -781.2% | -1474.7% | -989.1% | -2368.3% | -1662.7% | -6627.6% | · | -518.0% | -518.1% | -3140.6% | · | |
| Net Margin | -1385.0% | -686.2% | -1285.6% | -958.6% | -2276.3% | -1703.1% | -5932.3% | · | -497.5% | -490.3% | 2101.0% | · | |
| Pretax Margin | -1384.8% | -686.1% | -1285.6% | -958.6% | -2276.3% | -1703.1% | -6607.9% | · | -504.9% | -503.9% | -3096.9% | · | |
| EBITDA Margin | -1473.4% | -781.2% | -1474.7% | -961.9% | -2307.5% | -1553.5% | -6421.3% | · | -488.0% | -495.6% | -3140.6% | · | |
| ROA | -42.9% | -27.4% | -18.6% | -13.7% | -21.2% | -172.8% | -170.6% | · | -46.9% | -35.0% | 25.4% | · | |
| ROE | -55.2% | -32.2% | -21.1% | -15.3% | -17.0% | -498.7% | -224.9% | · | -51.0% | -37.4% | 30.8% | · | |
| ROIC | -66.7% | -38.2% | -24.7% | -16.2% | -12.9% | -971.7% | -279.0% | · | -71.9% | -48.2% | -24.3% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 13.7 | 16.8 | 20.5 | 15.5 | 1.1 | 3.2 | · | 7.6 | 12.7 | 13.6 | · | |
| Quick Ratio | 6.4 | 17.0 | 21.0 | 9.8 | 15.0 | 0.8 | 1.9 | · | 7.3 | 12.0 | 10.8 | · | |
| Debt / Equity | · | · | · | · | · | 0.3 | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 1.7 | · | |
| Receivables Turnover | 3.6 | 11.3 | 5.3 | 28.5 | 6.3 | 9.4 | 16.9 | · | 15.4 | 15.1 | 4.0 | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -41.2% | 126.7% | -13.7% | 160.2% | -31.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.8% | 72.0% | 15.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $750.0K | $869.0K | $334.0K | $488.0K | $127.0K | $86.0K | $2M | $3M | $513.0K | $130.0K | |
| Net Income TTM | $-14M | $-12M | $-10M | $-8M | $-8M | $-8M | $-8M | $-13M | $-12M | $-13M | $11M | $-5M | |
| Market Cap | $10M | $15M | $24M | $652M | $1.97B | $671M | $433M | · | $2.81B | $5.23B | $8.43B | · | |
| Enterprise Value | · | · | · | · | · | $668M | · | · | · | · | · | · | |
| P/E | -48.2 | -74.2 | -118.0 | -107.5 | -332.5 | -712.5 | -625.0 | -775.0 | -1137.5 | -2112.5 | -3387.5 | -3975.0 | |
| P/S | 10.2 | 8.9 | 31.8 | 750.7 | 5907.4 | 1375.4 | 3410.5 | · | 1205.3 | 1957.7 | 16437.5 | · | |
| P/B | 0.5 | 0.4 | 0.5 | 12.3 | 32.2 | 1073.9 | 159.9 | · | 167.3 | 182.4 | 203.5 | · | |
| P / Tangible Book | 0.5 | 0.4 | 0.5 | 12.3 | 32.2 | 1073.9 | · | · | · | · | · | · | |
| P / Cash Flow | -0.8 | -1.6 | -3.1 | -96.0 | -266.3 | -96.8 | -51.1 | · | -318.1 | -392.5 | -776.6 | · | |
| P / FCF | -0.7 | -1.5 | -2.5 | -88.3 | -258.9 | · | -51.1 | · | -301.1 | -370.0 | -642.4 | · | |
| EV / EBITDA | · | · | · | · | · | -88.1 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | 1369.0 | · | · | · | · | · | · | |
| Earnings Yield | -2.1% | -1.4% | -0.85% | -0.93% | -0.30% | -0.14% | -0.16% | -0.13% | -0.09% | -0.05% | -0.03% | -0.03% |
Gelir Tablosu 14
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $343.0K | $148.0K | $297.0K | $171.0K | $534.0K | $261.0K | $34.0K | $110.0K | $50.0K | $1M | $425.0K | $414.0K | $35.0K | $263.0K | $38.0K | $24.0K | |
| Cost of Revenue | $276.0K | $140.0K | $109.0K | $146.0K | $297.0K | $106.0K | $25.0K | $46.0K | $42.0K | $583.0K | $242.0K | $233.0K | $24.0K | $155.0K | $32.0K | $15.0K | |
| Gross Profit | $67.0K | $8.0K | $188.0K | $74.0K | $237.0K | $155.0K | $9.0K | $28.0K | $8.0K | $532.0K | $183.0K | $181.0K | $11.0K | $108.0K | $6.0K | $9.0K | |
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $768.0K | |
| SG&A Expense | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Operating Expenses | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Operating Income | $-3M | $-4M | $-4M | $-3M | $-4M | $-4M | $-4M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | |
| Other Non-op | $-315.0K | $-26.0K | $71.0K | $-10.0K | $234.0K | $312.0K | $350.0K | $387.0K | $379.0K | $427.0K | $423.0K | $412.0K | $375.0K | $396.0K | $235.0K | $114.0K | |
| Pretax Income | $-4M | $-4M | $4M | $-25M | $-4M | $-4M | $3M | $-20M | $-3M | $8M | $-3M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| Income Tax | · | $0 | · | · | · | $0 | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-4M | $-4M | $-3M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| EPS (Basic) | $-2.25 | $-2.34 | $-2.07 | $-1.68 | $-2.18 | $-2.45 | $-2.01 | $-1.78 | $-1.93 | $-1.62 | $-1.79 | $-1.41 | $-1.47 | $-1.50 | $-1.57 | $-2.50 | |
| Shares (Basic) | 1,677,000 | 1,676,000 | 1,673,000 | -3,269,000 | 1,665,000 | 1,638,000 | 1,631,000 | -3,257,000 | 1,633,000 | 1,631,000 | 1,631,000 | -3,221,000 | 1,616,000 | 1,613,000 | 1,612,000 | -49,008,000 | |
| EBITDA | $-3M | $-4M | $-3M | · | $-4M | $-4M | $-4M | · | $-4M | $-3M | $-3M | · | $-3M | $-3M | $-3M | · |
Bilanço 23
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | · | · | · | · | · | · | · | $26M | $26M | $26M | $28M | · | · | · | $26M | |
| Short-term Investments | $4M | $7M | $11M | $15M | $18M | $22M | $22M | $21M | $26M | $26M | $26M | $28M | $30M | $31M | $31M | $26M | |
| Receivables | $504.0K | $133.0K | $354.0K | $485.0K | $516.0K | $340.0K | $91.0K | $77.0K | $201.0K | $294.0K | $391.0K | $225.0K | $74.0K | $112.0K | $38.0K | $56.0K | |
| Prepaid Expense | $383.0K | $412.0K | $821.0K | $353.0K | $431.0K | $478.0K | $515.0K | $261.0K | $274.0K | $426.0K | $296.0K | $365.0K | $930.0K | $979.0K | $901.0K | $748.0K | |
| Current Assets | $11M | $14M | $18M | $22M | $25M | $28M | $32M | $35M | $38M | $40M | $42M | $45M | $47M | $49M | $51M | $55M | |
| PP&E (Net) | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Accum. Depreciation | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $872.0K | $784.0K | $702.0K | $779.0K | |
| Intangibles | $50.0K | $50.0K | $50.0K | $48.0K | $50.0K | · | · | $0 | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $315.0K | $346.0K | $347.0K | $346.0K | $346.0K | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | $31.0K | $30.0K | $30.0K | $11.0K | $11.0K | $11.0K | |
| Total Assets | $16M | $20M | $23M | $27M | $27M | $31M | $34M | $38M | $40M | $43M | $45M | $48M | $49M | $51M | $53M | $56M | |
| Accounts Payable | $234.0K | $649.0K | $613.0K | $1M | $616.0K | $1M | $649.0K | $373.0K | $612.0K | $567.0K | $646.0K | $546.0K | $274.0K | $301.0K | $287.0K | $169.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | |
| Capital Leases | $2M | $2M | $2M | $2M | $0 | $0 | $0 | $0 | $14.0K | · | · | $130.0K | · | · | · | · | |
| Total Liabilities | $4M | $4M | $4M | $5M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Common Stock | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | $191M | |
| Paid-in Capital | $84M | $84M | $84M | $83M | $83M | $83M | $83M | $82M | $82M | $82M | $81M | $81M | $81M | $80M | $80M | $80M | |
| Retained Earnings | $-262M | $-258M | $-254M | $-251M | $-248M | $-244M | $-240M | $-237M | $-234M | $-231M | $-228M | $-225M | $-223M | $-221M | $-218M | $-216M | |
| Treasury Stock | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $119.0K | $69.0K | · | · | $0 | |
| AOCI | $-389.0K | $-548.0K | $-716.0K | $-864.0K | $-941.0K | $-1M | $-861.0K | $-1M | $-1M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | |
| Stockholders' Equity | $12M | $16M | $19M | $22M | $25M | $28M | $32M | $35M | $38M | $40M | $42M | $45M | $47M | $49M | $51M | $53M | |
| Liabilities + Equity | $16M | $20M | $23M | $27M | $27M | $31M | $34M | $38M | $40M | $43M | $45M | $48M | $49M | $51M | $53M | $56M | |
| Shares Outstanding | 1,758,953 | 1,758,953 | 1,758,953 | 1,758,953 | 1,693,953 | 1,701,729 | 1,701,729 | 1,701,729 | 1,701,729 | 1,701,729 | 1,701,729 | 1,681,729 | 1,686,723 | 1,690,450 | 50,629,183 | 1,685,595 |
Nakit Akışı 10
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $227.0K | $221.0K | $236.0K | $244.0K | $247.0K | $239.0K | $232.0K | $224.0K | $206.0K | $152.0K | $149.0K | $129.0K | $109.0K | $110.0K | $89.0K | $44.0K | |
| Stock-based Comp | $247.0K | $189.0K | $304.0K | $201.0K | $152.0K | $261.0K | $216.0K | $203.0K | $438.0K | $473.0K | $364.0K | $351.0K | $356.0K | $404.0K | $387.0K | $369.0K | |
| Other Non-cash | · | · | $-1M | · | · | · | · | · | · | · | · | · | · | · | $-387.0K | · | |
| Operating Cash Flow | $-4M | $-4M | $-4M | $-2M | $-4M | $-3M | $-4M | $-3M | $-2M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-2M | |
| CapEx | $-2.0K | $411.0K | $448.0K | $348.0K | $-27.0K | $319.0K | $193.0K | $226.0K | $176.0K | $153.0K | $24.0K | $525.0K | $687.0K | $286.0K | $346.0K | $226.0K | |
| Investing Cash Flow | $3M | $4M | $4M | $3M | $4M | $-279.0K | $-193.0K | $4M | $-176.0K | $-149.0K | $2M | $1M | $738.0K | $-531.0K | $-5M | $-226.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $50.0K | · | · | · | $0 | |
| Financing Cash Flow | $-26.0K | $-18.0K | $-36.0K | $-28.0K | $-78.0K | $-34.0K | $-45.0K | $0 | $-91.0K | $-45.0K | $-45.0K | $-92.0K | $-107.0K | $-39.0K | $-538.0K | $-39.0K | |
| Net Change in Cash | $-416.0K | $449.0K | $-454.0K | $288.0K | $-349.0K | $-3M | $-4M | $2M | $-3M | $-2M | $-1M | $-227.0K | $-1M | $-2M | $-8M | $-2M | |
| Free Cash Flow | · | · | $-4M | · | · | · | $-4M | · | · | · | $-3M | · | · | · | $-3M | · |
Kârlılık 8
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.5% | 5.4% | 63.3% | · | 44.4% | 59.4% | 26.5% | · | 16.0% | 47.7% | 43.1% | · | 31.4% | 41.1% | 15.8% | · | |
| Operating Margin | -1006.7% | -2635.8% | -1190.6% | · | -724.2% | -1655.6% | -10670.6% | · | -7066.0% | -275.2% | -784.7% | · | -7857.1% | -1070.0% | -7276.3% | · | |
| Net Margin | -1098.5% | -2653.4% | -1166.7% | · | -680.3% | -1536.0% | -9641.2% | · | -6308.0% | -236.9% | -685.2% | · | -6785.7% | -919.4% | -6657.9% | · | |
| Pretax Margin | -1098.5% | -2653.4% | 1178.5% | · | · | · | -9641.2% | · | -6308.0% | · | -685.2% | · | -6785.7% | -919.4% | -6657.9% | · | |
| EBITDA Margin | -1006.7% | -2635.8% | -1111.1% | · | -724.2% | -1655.6% | -10670.6% | · | -7066.0% | -275.2% | -784.7% | · | -7857.1% | -1070.0% | -7042.1% | · | |
| ROA | -17.3% | -15.5% | -12.0% | · | -10.7% | -10.9% | -8.3% | · | -7.0% | -5.6% | -6.0% | · | -4.4% | -4.3% | -4.4% | · | |
| ROE | -20.4% | -18.0% | -13.6% | · | -11.7% | -11.7% | -8.8% | · | -7.5% | -5.9% | -6.3% | · | -4.7% | -4.5% | -4.6% | · | |
| ROIC | · | -25.1% | · | · | · | · | -11.3% | · | · | · | · | · | -5.9% | -5.8% | -5.5% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 7.6 | 9.8 | · | 9.9 | 10.7 | 14.9 | · | 15.3 | 17.3 | 18.6 | · | 20.2 | 21.8 | 27.2 | · | |
| Quick Ratio | 3.9 | 3.8 | 6.3 | · | 7.5 | 8.3 | 10.3 | · | 21.5 | 22.8 | 23.2 | · | 12.8 | 13.7 | 16.3 | · |
Verimlilik 2
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | 0.7 | 0.6 | 1.3 | · | 1.5 | 0.8 | 0.1 | · | 0.4 | 5.5 | 2.0 | · | 0.3 | 2.6 | 0.3 | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | $1M | · | $879.0K | $1M | $2M | · | $2M | $2M | $761.0K | · | $433.0K | $959.0K | $883.0K | · | |
| Net Income TTM | $-15M | $-15M | $-14M | · | $-14M | $-13M | $-12M | · | $-11M | $-10M | $-10M | · | $-9M | $-9M | $-9M | · | |
| Market Cap | $9M | $6M | $9M | · | $11M | $11M | $14M | · | $15M | $14M | $17M | · | $18M | $17M | $668M | · | |
| P/E | -43.6 | -28.8 | -40.8 | · | -54.0 | -56.0 | -66.6 | · | -74.6 | -70.8 | -84.2 | · | -88.8 | -83.2 | -110.0 | · | |
| P/S | 7.0 | 4.9 | 7.7 | · | 12.5 | 7.8 | 8.4 | · | 9.4 | 7.9 | 22.6 | · | 41.5 | 17.6 | 756.9 | · | |
| P/B | 0.8 | 0.4 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.3 | 13.2 | · | |
| P / Tangible Book | 0.8 | 0.4 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.3 | 13.2 | · | |
| P / Cash Flow | · | · | -2.2 | · | · | · | -3.7 | · | · | · | -5.6 | · | · | · | -273.8 | · | |
| P / FCF | · | · | -2.0 | · | · | · | -3.5 | · | · | · | -5.6 | · | · | · | -239.8 | · | |
| Earnings Yield | -2.3% | -3.5% | -2.5% | · | -1.8% | -1.8% | -1.5% | · | -1.3% | -1.4% | -1.2% | · | -1.1% | -1.2% | -0.91% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Gelir | $1M | $2M | $750.0K | $869.0K | $334.0K |
| Brüt Kâr Marjı % | 47.5% | 44.2% | 40.8% | 22.1% | 10.8% |
| Faaliyet Kâr Marjı % | -1473.4% | -781.2% | -1474.7% | -989.1% | -2368.3% |
| Net Gelir | $-14M | $-12M | $-10M | $-8M | $-8M |
Bilanço
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Cari Oran | 9.0 | 13.7 | 16.8 | 20.5 | 15.5 |
| Cari Oran | 6.4 | 17.0 | 21.0 | 9.8 | 15.0 |
Nakit Akışı
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-14M | $-10M | $-9M | $-7M | $-8M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 20 dosya · $1.3M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (+2 önceki Ç'ye göre) | 1 (-2 önceki Ç'ye göre) | 1 (-3 önceki Ç'ye göre) | 6 (+6 önceki Ç'ye göre) | +34K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $243.792 | 22.356 | 18,22% | Hisse senetleri |
| BlackRock, Inc. | $220.150 | 20.188 | 16,45% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $161.027 | 14.763 | 12,03% | Hisse senetleri |
| J. Safra Sarasin Holding AG | $140.049 | 27.300 | 10,46% | Hisse senetleri |
| JANE STREET GROUP, LLC | $133.695 | 12.260 | 9,99% | Hisse senetleri |
| STATE STREET CORP | $120.697 | 11.068 | 9,02% | Hisse senetleri |
| SCS Capital Management LLC | $119.955 | 11.000 | 8,96% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $86.760 | 7.956 | 6,48% | Hisse senetleri |
| Edge Capital Group, LLC | $79.034 | 11.761 | 5,91% | Hisse senetleri |
| VANGUARD GROUP INC | $15.534 | 4.339 | 1,16% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $8.249 | 886 | 0,62% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $7.274 | 667 | 0,54% | Hisse senetleri |
| MORGAN STANLEY | $840 | 77 | 0,06% | Hisse senetleri |
| UBS Group AG | $698 | 64 | 0,05% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $251 | 23 | 0,02% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $120 | 11 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $109 | 10 | 0,01% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $65 | 6 | 0,00% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $65 | 6 | 0,00% | Hisse senetleri |
| HUNTINGTON NATIONAL BANK | $1 | 1 | 0,00% | Hisse senetleri |
Şirket yöneticileri 38 içeriden öğrenenler · 12 yöneticiler · 23 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Thomas Boone Pickens III | Chief Executive Officer | 26 Mart 2021 A | 3.207.820 | 0 | 0 | $0 |
| Lance W Lord | Chief Executive Officer | 13 Kasım 2009 A | 275.000 | 0 | 0 | $0 |
| Michael E Kearney | Director, CEO & President | 09 Ağustos 2006 A | 56.143 | 0 | 0 | $0 |
| John Porter | Chief Financial Officer | 13 Eylül 2011 A | 350.000 | 0 | 0 | $0 |
| Brian K Harrington | Senior Vice President and CFO | 18 Temmuz 2008 A | 165.000 | 0 | 0 | $0 |
| James D Royston | President | 13 Kasım 2009 A | 300.000 | 0 | 0 | $0 |
| Nihanth Badugu | Chief Operating Officer | 22 Temmuz 2026 A | 5.000 | 0 | 0 | $0 |
| Rajesh K Mellacheruvu | Chief Operating Officer | 26 Mart 2021 A | 70.499 | 0 | 0 | $0 |
| Michael E Bain | Senior Vice President and COO | 11 Aralık 2006 I | 70.115 | 0 | 0 | $0 |
| Jr. Don Murphree White | See General Remarks | 13 Eylül 2011 A | 83.900 | 0 | 0 | $0 |
| Nicholas Morgan | Vice President & Controller | 09 Ağustos 2006 A | 0 | 0 | 0 | $0 |
| John B Satrom | Senior V.P. and Gen. Manager | 22 Eylül 2004 I | 0 | 0 | 0 | $0 |
| Matthew Kreps | Yönetim kurulu üyesi | 16 Temmuz 2026 A | 2.150 | 0 | 0 | $0 |
| Tom Wilkinson | Yönetim kurulu üyesi | 09 Temmuz 2026 A | 30.923 | 0 | 0 | $0 |
| John William Halinski | Yönetim kurulu üyesi | 09 Temmuz 2026 A | 12.211 | 0 | 0 | $0 |
| Charles Arch Winn | Yönetim kurulu üyesi | 09 Temmuz 2026 A | 10.950 | 0 | 0 | $0 |
| Eric Stober | Yönetim kurulu üyesi | 09 Temmuz 2026 A | 19.654 | 0 | 0 | $0 |
| Robert N Mcfarland | Yönetim kurulu üyesi | 09 Temmuz 2026 A | 11.205 | 0 | 0 | $0 |
| Thomas Wiley Wilkinson | Yönetim kurulu üyesi | 04 Ocak 2022 A | 127.559 | 0 | 0 | $0 |
| Daniel T Russler Jr | Yönetim kurulu üyesi | 04 Ocak 2022 A | 111.264 | 0 | 0 | $0 |
| CANTWELL RONALD W | Yönetim kurulu üyesi | 04 Ocak 2022 A | 114.963 | 0 | 0 | $0 |
| Mark Adams | Yönetim kurulu üyesi | 17 Aralık 2018 A | 113.003 | 0 | 0 | $0 |
| Michael R. Humphrey | Yönetim kurulu üyesi | 09 Mayıs 2017 A | 50.000 | 0 | 0 | $0 |
| Sha-Chelle Manning | Yönetim kurulu üyesi | 09 Mayıs 2017 A | 106.710 | 0 | 0 | $0 |
| William F Readdy | Yönetim kurulu üyesi | 09 Aralık 2016 D | 195.104 | 0 | 0 | $0 |
| John A Oliva | Yönetim kurulu üyesi | 13 Eylül 2011 A | 170.000 | 0 | 0 | $0 |
| Barry A Williamson | Yönetim kurulu üyesi | 18 Temmuz 2008 A | 225.000 | 0 | 0 | $0 |
| Roscoe Michael Moore III | Yönetim kurulu üyesi | 12 Aralık 2006 A | 5.000 | 0 | 0 | $0 |
| Edward E David JR | Yönetim kurulu üyesi | 12 Aralık 2006 A | 1.000 | 0 | 0 | $0 |
| Shelley A Harrison | Yönetim kurulu üyesi | 01 Aralık 2005 A | 0 | 0 | 0 | $0 |
| James R Thompson JR | Yönetim kurulu üyesi | 01 Aralık 2005 A | — | 0 | 0 | $0 |
| Richard M Fairbanks | Yönetim kurulu üyesi | 01 Aralık 2004 A | 0 | 0 | 0 | $0 |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10% sahip | 06 Kasım 2007 S | 1.196.463 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 03 Ekim 2025 S | 0 | 0 | 2 | $-1.624.961 |
| Scott Neiboer | — | 30 Eylül 2009 S | 1.071.344 | 0 | 0 | $0 |
| Michael E Chewning | — | 09 Ağustos 2006 A | — | 0 | 0 | $0 |
| Richard S Bodman | — | 01 Aralık 2004 A | — | 0 | 0 | $0 |
| Daniel A Bland JR | — | 17 Ağustos 2004 A | 9.938 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 12 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| BML Investment Partners, L.P., Leonard Braden Michael ×2 başvurular | 07 Ekim 2025 | 0,00% | Değişiklik | — | SEC |
| Thomas Boone Pickens III (2) ×3 başvurular | 31 Mart 2021 | — | İlk başvuru | — | SEC |
| Thomas Boone Pickens III ×4 başvurular | 10 Ocak 2017 | — | İlk başvuru | — | SEC |
| Robert Scott Nieboer | 06 Ekim 2009 | — | İlk başvuru | — | SEC |
| Trace Partners, L.P., Curtiswood Capital, LLC, Trace Management, LLC, Robert Scott Nieboer, Mark Forward Eberle ×3 başvurular | 30 Eylül 2009 | — | İlk başvuru | Pasif yatırım | SEC |
| SMH Capital Advisors, Inc. | 20 Temmuz 2009 | — | İlk başvuru | Pasif yatırım | SEC |
| Trace Partners, LP, Curtiswood Capital, LLC, Trace Management, LLC, Robert Scott Nieboer, Mark Forward Eberle | 16 Haziran 2008 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 03 Ocak 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 02 Ağustos 2005 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 29 Ekim 2004 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 18 Ekim 2004 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 14 Eylül 2004 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 22.356 SH | 08 Ağustos 2026 | Günlük |